The Breast Cancer Surgeon
  • Home
  • About
    • Make An Appointment
    • Curriculum Vitae
    • Honors and Awards
    • Selected Lectures
  • Genetics and Risk factors
    • Genetics and Family History
      • Bermuda Risk Clinic
      • Slide Set for High Risk identification
      • Media
      • Publications
      • Bia in the Reporting of Family History
    • Risk Models and Guidelines
      • FAQ Main Page
      • Simplifying clinical use – genetic risk prediction model BRCAPRO
      • HL7 XML-formatted risk prediction service
      • Risk Clinic Module
    • High Risk Lesions (Atypia/LCIS)
      • Atypical Breast Legions – How high is risk?
  • EHR & CDS
    • Clinical Decision Support for Medical Students
    • The feasibility of using natural language processing to extract clinical information from breast pathology reports
    • Modular EHR
    • Media Video on eCancer TV regarding Electronic Health Records
    • Whats A Matta With EHRs Today
    • Family History Module ASHG
    • Publications EHR
    • HughesRiskApps.Net
      • HughesRiskApps Pedigree Module
      • Breast Surgery Module
  • Breast Cancer/Diseases
    • Breast Cancer and Breast Diseases
    • Breast Cancer Older Women
    • Technique for Axillary Dissection Using the Bookwalter Retractor
  • Blog
Select Page

Why does the Myriad model sometimes give very low risks of mutation?

by kshughes | Mar 3, 2016 | Hereditary, Myriad

The Myriad Model, also known as the Frank model, was one of the first models to estimate the risk of having a BRCA1 or BRCA2 mutation based on family history.  It is the only breast cancer risk model that directly relates to actual genetic test results, and it is...

Why does the Myriad Model seem to give low rates of mutations for very strong family histories?

by kshughes | Mar 3, 2016 | Hereditary, Myriad

The Myriad Model, also known as the Frank model, was one of the first models to estimate the risk of having a BRCA1 or BRCA2 mutation based on family history.  It is the only breast cancer risk model that directly relates to actual genetic test results, and it is...

Categories

  • Atypia/LCIS
  • Biopsy
  • Blog
  • Boadicea
  • BRCAPRO
  • Breast Cancer & Breast Disease
  • Breast disease
  • Claus
  • EHR
  • EHR Articles
  • FAQ
  • Gail
  • Genetic Testing
  • Guidelines
  • Hereditary
  • Hereditary cancer
  • Hughes RiskApps
  • Hughes RiskApps Express
  • Lifetime Risk
  • Models
  • MRI
  • Myriad
  • Ovarian Cancer
  • Population Level Risk
  • Race/Ethnicity
  • Surgery
  • Tyrer Cuzick

Archives

  • July 2016
  • May 2016
  • March 2016
  • February 2016
  • March 2014
  • December 2013
  • July 2013
  • July 2012
  • June 2012
  • March 2012

Recent Posts

  • Knowledge bases for Genetics and Risk Assessment
  • Genetic Panel Testing: Incidental Findings and Actionable Mutations
  • Should a Core Biopsy be counted in the Gail model?
  • VIDEO: Treat most older women with stage I breast cancer with lumpectomy only
  • Patients with a strong family history and ones with no family history can sometimes have the same risk. Why?
  • Facebook
  • RSS

Designed by Begin Bound, LLC